Chronic Disease in China: Geographic and Socioeconomic Determinants Among Persons Aged 60 and Older

Binbin Su(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoying Zheng(Hohai University), Jun Li(Fudan University), Junqing Xie(Nuffield Orthopaedic Centre), Dan Li(University of Oklahoma Health Sciences Center), Xiaolan Wu(State Council of the People's Republic of China), Yiran Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Daniel Prieto‐Alhambra(Nuffield Orthopaedic Centre)
Journal of the American Medical Directors Association
November 10, 2022
10.1016/j.jamda.2022.10.002
Cited by 135

Related Papers

European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
|Nephrology Dialysis Transplantation|2020|185
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
|The Lancet Respiratory Medicine|2024|166
The Effects of Cardiopulmonary Bypass on the Number of Cerebral Microemboli and the Incidence of Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery
|Anesthesia & Analgesia|2009|148
Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014
|BMJ Open|2018|128
Identification of Noncytotoxic and IL-10–Producing CD8+AT2R+ T Cell Population in Response to Ischemic Heart Injury
|The Journal of Immunology|2010|100